These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32850919)

  • 1. Intrahepatic Expression of Fatty Acid Translocase CD36 Is Increased in Obstructive Sleep Apnea.
    Rey E; Del Pozo-Maroto E; Marañón P; Beeler B; García-García Y; Landete P; Isaza SC; Farré R; García-Monzón C; Almendros I; González-Rodríguez Á
    Front Med (Lausanne); 2020; 7():450. PubMed ID: 32850919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of intermittent hypoxia on hepatic expression of fatty acid translocase CD36 in lean and diet-induced obese mice.
    Ji Y; Liang Y; Chu PH; Ge M; Yeung SC; Ip MSM; Mak JCW
    Biomed J; 2023 Oct; 46(5):100566. PubMed ID: 36244649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between the Severity of Nocturnal Hypoxia in Obstructive Sleep Apnea and Non-Alcoholic Fatty Liver Damage.
    Cakmak E; Duksal F; Altinkaya E; Acibucu F; Dogan OT; Yonem O; Yilmaz A
    Hepat Mon; 2015 Nov; 15(11):e32655. PubMed ID: 26834793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive sleep apnea and non-alcoholic Fatty liver disease: is the liver another target?
    Mirrakhimov AE; Polotsky VY
    Front Neurol; 2012; 3():149. PubMed ID: 23087670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.
    Sundaram SS; Halbower A; Pan Z; Robbins K; Capocelli KE; Klawitter J; Shearn CT; Sokol RJ
    J Hepatol; 2016 Sep; 65(3):560-9. PubMed ID: 27501738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
    Rey E; Meléndez-Rodríguez F; Marañón P; Gil-Valle M; Carrasco AG; Torres-Capelli M; Chávez S; Del Pozo-Maroto E; Rodríguez de Cía J; Aragonés J; García-Monzón C; González-Rodríguez Á
    Liver Int; 2020 Oct; 40(10):2553-2567. PubMed ID: 32432822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of obstructive sleep apnea on fatty liver disease: role of chronic intermittent hypoxia.
    Türkay C; Ozol D; Kasapoğlu B; Kirbas I; Yıldırım Z; Yiğitoğlu R
    Respir Care; 2012 Feb; 57(2):244-9. PubMed ID: 21762556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin improves hepatic steatosis via CD36 pathway.
    Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
    J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obstructive sleep apnea is associated with preserved bone mineral density in healthy elderly subjects.
    Sforza E; Thomas T; Barthélémy JC; Collet P; Roche F
    Sleep; 2013 Oct; 36(10):1509-15. PubMed ID: 24082310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.
    Qi JC; Huang JC; Lin QC; Zhao JM; Lin X; Chen LD; Huang JF; Chen X
    Sleep Breath; 2016 May; 20(2):529-35. PubMed ID: 26174847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Hepatic Steatosis and Obstructive Sleep Apnea in Children and Adolescents with Obesity.
    Carotenuto M; Di Sessa A; Esposito M; Grandone A; Marzuillo P; Bitetti I; Umano GR; Precenzano F; Miraglia Del Giudice E; Santoro N
    Children (Basel); 2021 Nov; 8(11):. PubMed ID: 34828697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of obstructive sleep apnea on nonalcoholic fatty liver disease in patients with severe obesity.
    Benotti P; Wood GC; Argyropoulos G; Pack A; Keenan BT; Gao X; Gerhard G; Still C
    Obesity (Silver Spring); 2016 Apr; 24(4):871-7. PubMed ID: 26880657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of intermittent hypoxia impacts metabolic outcomes and severity of murine NAFLD.
    Barnes LA; Xu Y; Sanchez-Azofra A; Moya EA; Zhang MP; Crotty Alexander LE; Malhotra A; Mesarwi O
    Front Sleep; 2023; 2():. PubMed ID: 38077744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstructive sleep apnea, intermittent hypoxia and non-alcoholic fatty liver disease.
    Ji Y; Liang Y; Mak JCW; Ip MSM
    Sleep Med; 2022 Jul; 95():16-28. PubMed ID: 35537279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.
    Hany M; Abouelnasr AA; Abdelkhalek MH; Ibrahim M; Aboelsoud MR; Hozien AI; Torensma B
    Int J Obes (Lond); 2023 Dec; 47(12):1200-1213. PubMed ID: 37696927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Obstructive Sleep Apnea with Nonalcoholic Fatty Liver Disease: Evidence, Mechanism, and Treatment.
    Wang L; Liu H; Zhou L; Zheng P; Li H; Zhang H; Liu W
    Nat Sci Sleep; 2024; 16():917-933. PubMed ID: 39006248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of symptoms and oxygen desaturation index in predicting childhood obstructive sleep apnea.
    Chang L; Wu J; Cao L
    Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):365-71. PubMed ID: 23246417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and risk factors for fatty liver in Tunisian adults with obstructive sleep apnea].
    Maâlej S; Jedidi S; Hannachi H; Gharsalli H; Sahnoun I; Neji H; El Gharbi L
    Rev Mal Respir; 2020 Jan; 37(1):8-14. PubMed ID: 31899023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Oxygen Desaturation Time During Sleep Is a Risk Factor for NASH in Patients With Obstructive Sleep Apnea: A Prospective Cohort Study.
    Landete P; Fernández-García CE; Aldave-Orzaiz B; Hernández-Olivo M; Acosta-Gutiérrez CM; Zamora-García E; Ancochea J; González-Rodríguez Á; García-Monzón C
    Front Med (Lausanne); 2022; 9():808417. PubMed ID: 35280896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.